Georgia · 86664

Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Georgia

Georgia Medicare Avg
$14.98
0% above national avg
National Medicare Avg
$14.94
All states combined
Billed Charge (GA)
$112.56
What providers submit
Est. Commercial (GA)
$33.71
National avg: $33.46
Est. Cash / Self-Pay (GA)
$42.19
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

633
Services in GA
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Georgia

Provider Medicare Services
Quest Diagnostics Clinical... $14.98 632

Georgia Pricing in Context

In Georgia, CPT code 86664 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen) carries an average Medicare payment of $14.98 — 0% above the national benchmark of $14.94. 2 providers across the state submitted claims for this procedure in 2023, performing 633 total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Georgia is $112.56, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Georgia lands near $33.71, with self-pay cash prices typically around $42.19. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost in Georgia?

The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Georgia is $14.98, which is 0% above the national average of $14.94. Providers in GA typically bill $112.56 for this procedure.

What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost with insurance in Georgia?

With commercial insurance in Georgia, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs an estimated $33.71. Without insurance, the estimated cash price is $42.19. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in Georgia?

2 providers in Georgia billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in 2023, performing 633 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cheaper in Georgia than the national average?

No — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs 0% above the national average in Georgia. The state average Medicare payment is $14.98 compared to $14.94 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial